Nitroblue tetrazolium test is a blood test that measures the ability of the immune system to convert the colorless nitroblue tetrazolium (NBT) to a deep blue. This test is performed as a screen for chronic granulomatous disease (CGD). If an individual has CGD, the chemicals in their blood will not turn blue when exposed to the NBT.
Review Date:4/29/2005
Reviewed By: Frank A. Greco, M.D., Ph.D., Director, Biophysical Laborartory, The Lahey Clinic, Burlington, MA. Review provided by VeriMed Healthcare Network.
Reviewed By: Frank A. Greco, M.D., Ph.D., Director, Biophysical Laborartory, The Lahey Clinic, Burlington, MA. Review provided by VeriMed Healthcare Network.
Learn more about what ails you. Here are some common symptoms.
A comprehensive guide with three thousand articles, including images and multimedia.
